Globus Medical, Inc. Class A (GMED) is listed on NYSE in Medical Device Stocks. It is $82.97, +0.52%, with a $11.1B market cap. RSI is 53.1, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 53.1 Neutral
Market Cap $11.1B
Volume 1.3M
Fundamentals — 10-Q Q2 2026
Revenue $1.5B
Net Income $275.9M
EPS $2.00
Gross Margin 69.3%
Operating Margin 21.5%
Net Margin 17.8%
P/E Ratio 41.5x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Zarrilli Stephen T | Insider | Sell | 25,000 | $87.04 | $2.2M | 2026 Aug 18 |
| Davidar David D | Insider | Sell | 25,000 | $80.76 | $2.0M | 2026 Jun 5 |
| Huller Kelly | EVP, GC, Corporate Secretary | Sell | 20,000 | $94.50 | $1.9M | 2026 Feb 25 |
| Norwalk Leslie V | Director | Sell | 4,000 | $88.85 | $355,400 | 2025 Dec 12 |
| Kline Kyle | Senior Vice President, CFO | Sell | 18,542 | $90.00 | $1.7M | 2025 Dec 1 |
| Huller Kelly | SVP, GC, Corporate Secretary | Sell | 7,500 | $90.00 | $675,000 | 2025 Nov 25 |
| Davidar David D | Director | Sell | 25,000 | $86.00 | $2.1M | 2025 Nov 12 |
| Zarrilli Stephen T | Director | Sell | 25,000 | $84.29 | $2.1M | 2025 Nov 11 |
| Rhoads Ann D | Director | Sell | 10,000 | $81.80 | $818,000 | 2025 Nov 10 |
| Rhoads Ann D | Director | Sell | 10,000 | $58.46 | $584,600 | 2025 Sep 15 |
| Rhoads Ann D | Director | Sell | 7,500 | $78.68 | $590,100 | 2025 Feb 28 |
| Pfeil Keith W | COO, CFO | Sell | 14,167 | $88.29 | $1.3M | 2025 Jan 10 |
| Huller Kelly | SVP, GC, Corporate Secretary | Sell | 2,500 | $87.00 | $217,500 | 2024 Dec 2 |
| Lemaitre Dan | Director | Sell | 14,375 | $85.00 | $1.2M | 2024 Nov 22 |
| Davidar David D | Director | Sell | 40,000 | $85.00 | $3.4M | 2024 Nov 22 |
| Scavilla Daniel T | President, CEO | Sell | 130,000 | $85.00 | $11.1M | 2024 Nov 21 |
| Scavilla Daniel T | President, CEO | Sell | 60,000 | $80.02 | $4.8M | 2024 Nov 6 |
| Huller Kelly | SVP, GC, Corporate Secretary | Sell | 5,000 | $81.01 | $405,050 | 2024 Nov 6 |
| Huller Kelly | SVP, GC, Corporate Secretary | Sell | 7,500 | $75.02 | $562,650 | 2024 Oct 16 |
| Davidar David D | Director | Sell | 50,000 | $75.04 | $3.8M | 2024 Oct 16 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $91.12 | 67.1 | $15.5B |
| | $103.89 | 70.7 | $4.7B |
| | $179.79 | 57.4 | $10.6B |
| | $125.31 | 91.6 | $4.3B |
Take GMED further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put GMED in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Globus Medical, Inc. Class A next reports.
Set alerts on GMED
Get notified when Globus Medical, Inc. Class A hits your price targets or technical conditions are met.
Get Started Free